• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中毒性多巴胺代谢物 DOPAL 蓄积的决定因素。

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.

机构信息

Clinical Neurocardiology Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1620, USA.

出版信息

J Neurochem. 2013 Sep;126(5):591-603. doi: 10.1111/jnc.12345. Epub 2013 Jul 22.

DOI:10.1111/jnc.12345
PMID:23786406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4096629/
Abstract

Intra-neuronal metabolism of dopamine (DA) begins with production of 3,4-dihydroxyphenylacetaldehyde (DOPAL),which is toxic. According to the 'catecholaldehyde hypothesis', DOPAL destroys nigrostriatal DA terminals and contributes to the profound putamen DA deficiency that characterizes Parkinson’s disease (PD). We tested the feasibility of using post-mortem patterns of putamen tissue catechols to examine contributions of altered activities of the type 2 vesicular monoamine transporter (VMAT2) and aldehyde dehydrogenase(ALDH) to the increased DOPAL levels found in PD. Theoretically, the DA : DOPA concentration ratio indicates vesicular uptake, and the 3,4-dihydroxyphenylacetic acid: DOPAL ratio indicates ALDH activity. We validated these indices in transgenic mice with very low vesicular uptake VMAT2-Lo) or with knockouts of the genes encoding ALDH1A1 and ALDH2 (ALDH1A1,2 KO), applied these indices in PD putamen, and estimated the percent decreases in vesicular uptake and ALDH activity in PD. VMAT2-Lo mice had markedly decreased DA:DOPA (50 vs. 1377, p < 0.0001),and ALDH1A1,2 KO mice had decreased 3,4-dihydroxyphenylacetic acid:DOPAL (1.0 vs. 11.2, p < 0.0001). In PD putamen, vesicular uptake was estimated to be decreased by 89% and ALDH activity by 70%. Elevated DOPAL levels in PD putamen reflect a combination of decreased vesicular uptake of cytosolic DA and decreased DOPAL detoxification by ALDH.

摘要

多巴胺(DA)的神经元内代谢始于 3,4-二羟基苯乙醛(DOPAL)的产生,而 DOPAL 具有毒性。根据“儿茶酚醛假说”,DOPAL 破坏黑质纹状体 DA 末梢,并导致帕金森病(PD)的纹状体 DA 严重缺乏。我们测试了使用纹状体组织儿茶酚的死后模式来检查改变的 2 型囊泡单胺转运体(VMAT2)和醛脱氢酶(ALDH)的活性对 PD 中发现的 DOPAL 水平升高的贡献的可行性。理论上,DA:DOPA 浓度比表示囊泡摄取,而 3,4-二羟基苯乙酸:DOPAL 比表示 ALDH 活性。我们在囊泡摄取极低的 VMAT2 低表达(VMAT2-Lo)转基因小鼠或编码 ALDH1A1 和 ALDH2 的基因敲除(ALDH1A1,2 KO)小鼠中验证了这些指标,将这些指标应用于 PD 纹状体,并估计 PD 中囊泡摄取和 ALDH 活性的百分比降低。VMAT2-Lo 小鼠的 DA:DOPA(50 比 1377,p <0.0001)明显降低,而 ALDH1A1,2 KO 小鼠的 3,4-二羟基苯乙酸:DOPAL(1.0 比 11.2,p <0.0001)降低。在 PD 纹状体中,估计囊泡摄取降低了 89%,ALDH 活性降低了 70%。PD 纹状体中 DOPAL 水平升高反映了胞质 DA 囊泡摄取减少和 ALDH 降低 DOPAL 解毒的综合作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/2c32dfe41a7b/nihms574188f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/266a44b54b24/nihms574188f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/5f5435dc8128/nihms574188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/740068e94771/nihms574188f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/e287149d28aa/nihms574188f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/b25355701c19/nihms574188f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/539316c0f8e7/nihms574188f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/357458bd9e6c/nihms574188f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/2c32dfe41a7b/nihms574188f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/266a44b54b24/nihms574188f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/5f5435dc8128/nihms574188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/740068e94771/nihms574188f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/e287149d28aa/nihms574188f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/b25355701c19/nihms574188f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/539316c0f8e7/nihms574188f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/357458bd9e6c/nihms574188f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b6d/4096629/2c32dfe41a7b/nihms574188f8.jpg

相似文献

1
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.帕金森病中毒性多巴胺代谢物 DOPAL 蓄积的决定因素。
J Neurochem. 2013 Sep;126(5):591-603. doi: 10.1111/jnc.12345. Epub 2013 Jul 22.
2
Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.鱼藤酮降低细胞内醛脱氢酶活性:对帕金森病发病机制的影响。
J Neurochem. 2015 Apr;133(1):14-25. doi: 10.1111/jnc.13042. Epub 2015 Feb 25.
3
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.多系统萎缩中囊泡储存和醛脱氢酶活性降低。
Parkinsonism Relat Disord. 2015 Jun;21(6):567-72. doi: 10.1016/j.parkreldis.2015.03.006. Epub 2015 Mar 20.
4
Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.囊泡摄取阻断会在 PC12 细胞中产生有毒的多巴胺代谢物 3,4-二羟基苯乙醛:与帕金森病发病机制的相关性。
J Neurochem. 2012 Dec;123(6):932-43. doi: 10.1111/j.1471-4159.2012.07924.x. Epub 2012 Oct 25.
5
Catechols in post-mortem brain of patients with Parkinson disease.帕金森病患者死后大脑中的儿茶酚胺。
Eur J Neurol. 2011 May;18(5):703-10. doi: 10.1111/j.1468-1331.2010.03246.x. Epub 2010 Nov 12.
6
Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.苯菌灵、乙醛脱氢酶、3,4-二羟基苯乙醛与帕金森病发病机制的儿茶酚醛假说
Chem Res Toxicol. 2014 Aug 18;27(8):1359-61. doi: 10.1021/tx5002223. Epub 2014 Jul 24.
7
Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease.二羟苯乙酮降低治疗可改善鱼藤酮诱导的大鼠运动和神经化学异常:与帕金森病发病机制的儿茶醛假说相关。
Int J Mol Sci. 2023 Aug 7;24(15):12522. doi: 10.3390/ijms241512522.
8
The catecholaldehyde hypothesis: where MAO fits in.儿茶酚醛假说:MAO 在其中的作用。
J Neural Transm (Vienna). 2020 Feb;127(2):169-177. doi: 10.1007/s00702-019-02106-9. Epub 2019 Dec 5.
9
The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.儿茶酚醛假说在儿茶酚胺能神经元变性发病机制中的作用:已知与未知。
Int J Mol Sci. 2021 Jun 1;22(11):5999. doi: 10.3390/ijms22115999.
10
Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.氧化应激产物会抑制多巴胺分解代谢中的醛氧化和还原途径,从而使一种反应性中间体的水平升高。
Chem Res Toxicol. 2009 May;22(5):835-41. doi: 10.1021/tx800405v.

引用本文的文献

1
Ferroptosis-A Shared Mechanism for Parkinson's Disease and Type 2 Diabetes.铁死亡:帕金森病和 2 型糖尿病的共同机制。
Int J Mol Sci. 2024 Aug 14;25(16):8838. doi: 10.3390/ijms25168838.
2
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.固有细胞类型特异性神经生物学调节的选择性多巴胺能神经毒性。
Neurotoxicology. 2024 Jul;103:266-287. doi: 10.1016/j.neuro.2024.06.016. Epub 2024 Jul 2.
3
Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?重新思考帕金森病:多巴胺减少疗法是否具有临床应用价值?

本文引用的文献

1
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.醛脱氢酶抑制作为帕金森病的发病机制。
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):636-41. doi: 10.1073/pnas.1220399110. Epub 2012 Dec 24.
2
Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.囊泡摄取阻断会在 PC12 细胞中产生有毒的多巴胺代谢物 3,4-二羟基苯乙醛:与帕金森病发病机制的相关性。
J Neurochem. 2012 Dec;123(6):932-43. doi: 10.1111/j.1471-4159.2012.07924.x. Epub 2012 Oct 25.
3
Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons.
J Neurol. 2024 Aug;271(8):5687-5695. doi: 10.1007/s00415-024-12526-7. Epub 2024 Jun 21.
4
Neurotoxicology of dopamine: Victim or assailant?多巴胺的神经毒性:受害者还是攻击者?
Neurotoxicology. 2024 Jul;103:175-188. doi: 10.1016/j.neuro.2024.06.001. Epub 2024 Jun 8.
5
Effects of latroeggtoxin-VI on dopamine and α-synuclein in PC12 cells and the implications for Parkinson's disease.Latroeggtoxin-VI 对 PC12 细胞中多巴胺和α-突触核蛋白的影响及其对帕金森病的意义。
Biol Res. 2024 Mar 16;57(1):9. doi: 10.1186/s40659-024-00489-y.
6
Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.帕金森病患者多巴胺能脑区及非帕金森病老年人脑组织中多巴胺及相关儿茶酚的氧化。
J Neural Transm (Vienna). 2024 Mar;131(3):213-228. doi: 10.1007/s00702-023-02718-2. Epub 2024 Jan 18.
7
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease.帕金森病中线粒体中单胺氧化酶、多巴胺、α-突触核蛋白与基因之间的毒性相互作用。
J Neural Transm (Vienna). 2024 Jun;131(6):639-661. doi: 10.1007/s00702-023-02730-6. Epub 2024 Jan 9.
8
Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson's Disease.醛还原组合物在脂多糖诱导的帕金森病神经炎症模型中的神经保护作用。
Molecules. 2023 Dec 7;28(24):7988. doi: 10.3390/molecules28247988.
9
Neurodegenerative Etiology of Aromatic L-Amino Acid Decarboxylase Deficiency: a Novel Concept for Expanding Treatment Strategies.芳香族 L-氨基酸脱羧酶缺乏症的神经退行性病因:拓展治疗策略的新概念。
Mol Neurobiol. 2024 May;61(5):2996-3018. doi: 10.1007/s12035-023-03684-2. Epub 2023 Nov 13.
10
Locus coeruleus neuromelanin accumulation and dissipation across the lifespan.蓝斑核神经黑色素在整个生命周期中的积累与消散。
bioRxiv. 2023 Oct 23:2023.10.17.562814. doi: 10.1101/2023.10.17.562814.
多巴胺储存失调会增加黑质神经元中α-突触核蛋白的易感性。
Neurobiol Dis. 2012 Sep;47(3):367-77. doi: 10.1016/j.nbd.2012.05.012. Epub 2012 May 31.
4
A molecular signature in blood identifies early Parkinson's disease.血液中的分子特征可识别早期帕金森病。
Mol Neurodegener. 2012 May 31;7:26. doi: 10.1186/1750-1326-7-26.
5
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.帕金森病和其他突触核蛋白病中枢儿茶酚胺缺乏的脑脊液生物标志物。
Brain. 2012 Jun;135(Pt 6):1900-13. doi: 10.1093/brain/aws055. Epub 2012 Mar 26.
6
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.缺乏细胞质和线粒体醛脱氢酶的小鼠的神经退行性变和运动功能障碍:对帕金森病的影响。
PLoS One. 2012;7(2):e31522. doi: 10.1371/journal.pone.0031522. Epub 2012 Feb 22.
7
Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative diseases.神经退行性疾病中的应激、适应负荷、儿茶酚胺和其他神经递质。
Cell Mol Neurobiol. 2012 Jul;32(5):661-6. doi: 10.1007/s10571-011-9780-4.
8
Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone.3,4-二羟苯乙醛的氧化,一种有毒的多巴胺代谢物,生成半醌自由基和邻醌。
J Biol Chem. 2011 Jul 29;286(30):26978-86. doi: 10.1074/jbc.M111.249532. Epub 2011 Jun 3.
9
Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies.囊泡单胺转运体 2 蛋白在人脑内的分布:对脑影像研究的启示。
J Cereb Blood Flow Metab. 2011 Oct;31(10):2065-75. doi: 10.1038/jcbfm.2011.63. Epub 2011 Apr 27.
10
Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.多巴胺转运体和囊泡单胺转运体基因敲除小鼠:对帕金森病的影响
Methods Mol Med. 2001;62:179-90. doi: 10.1385/1-59259-142-6:179.